Co-Chair’s Column
George G. Gordon and Michael S. McFalls
The Road to Genzyme: A Look
at Competition in Innovation Cases at the Federal Trade Commission
Robin Moore and Holly Vedova
Drug Importation From Canada:
What Does Canadian Competition Law Have to Say?
Peter Glossup
Proposed Reforms in the U.S.
Patent Regime to Combat Patents That Stifle Competition
Robert D. Stoner
From Magill to Microsoft:
Is the European Union’s Insistence on Compulsory Licensing of
Intellectual Property Rights a Threat to Innovation?
Robert G. Badal and Michael J. Lawrence
Case Developments Involving
Antitrust and Intellectual Property
John E. Sindoni
Chair's Column.
George G. Gordon and Michael S. McFalls
A Continental Divide:
How the United States and the European Union Differ in Their
Antitrust Treatment of a Firm's Unilateral Refusal to License
Intellectual Property; Lessons from Via Technologies.
Robert G. Badal and Michael J. Lawrence
Are Anti-Reverse-Engineering
Clauses Lawful Under Antitrust Law?
Henry C. Su and Mark S. Ostrau
Developments in
Federal Antitrust Enforcement and Intellectual Property.
Robin Moore
Case Developments
Involving Antitrust and Intellectual Property.
Ryan Thomas
Predation through
Government Process: A Moment of Consensus.
John Martin and Courtney Sydnor
Strategic Consideration
when Asserting Defenses against a Claim for Infringement of
a Patent the Reads on an Industry Standard.
Mark A. Flagel and Michael J. Lawrence
Finding Reason Through Extremes: From Nine No-No's to Patent
"Immunity".
Edward G. Biester, III
Cross-Licensing and Patent Pools: Legal Framework and Practical
Issues.
M. Howard Morse
Recent Cases Involving
Antitrust and Intellectual Property.
Brian K. Grube, Gregory Luib and Ryan Thomas
